Publications by authors named "W Kostucki"

Article Synopsis
  • Some doctors give cholesterol-lowering drugs to people with type 2 diabetes, but it's unclear if they actually help prevent heart problems.
  • A review found only four good studies on this, and most of them showed that these drugs didn't really lower the risk of dying or having heart issues in these patients.
  • The review suggests changing medical guidelines since it didn’t find enough proof that these drugs are helpful for people with type 2 diabetes.
View Article and Find Full Text PDF
Article Synopsis
  • The JUPITER trial was a study that looked at a cholesterol-lowering drug and its effects on heart disease in people who didn't have heart issues and had normal or low cholesterol levels.
  • The trial was stopped early, and it showed some confusing results, like fewer strokes and heart attacks but no big change in how many people died from these issues.
  • The findings suggest using this drug to prevent heart disease might not be a good idea, and it raises questions about how commercial interests could affect research results.
View Article and Find Full Text PDF

This case report demonstrates embolization of echogenic material detected by transoesophageal echocardiography during a cemented total hip arthroplasty in a 76-yr-old woman without patent foramen ovale. During the placement of the acetabular and femoral components, and during relocation of the hip joint, a "snow flurry" appearing in the right atrium was followed by several highly echogenic and mobile emboli of various sizes, some of them with a vermiform shape 1 to 5 cm long. At skin closure, echogenic material was seen in the right branch of the pulmonary artery adherent to the vascular wall of the bifurcation of the main pulmonary artery.

View Article and Find Full Text PDF

In a double-blind, placebo-controlled, crossover study, the effects of therapeutic doses of the new tricyclic antidepressant tianeptine on cardiovascular function were closely monitored in 21 healthy volunteers during a 2-week treatment period. Blood pressure measurements, ECG recording, 24-h Holter monitoring, and echocardiography were carried out at 1-week intervals. Isotopic ventriculography was measured twice under each treatment.

View Article and Find Full Text PDF